|
1
|
Kubota Y, Sunouchi K, Ono M, Sawada T and
Muto T: Local immunity and metastasis of colorectal carcinoma. Dis
Colon Rectum. 35:645–650. 1922. View Article : Google Scholar
|
|
2
|
Yasutomo K: The cellular and molecular
mechanism of CD4/CD8 lineage commitment. J Med Invest. 49:1–6.
2002.PubMed/NCBI
|
|
3
|
Lonial S, Torre C, David E, Harris W,
Arellano M and Waller EK: Regulation of alloimmune responses by
dendritic cell subsets. Exp Hematol. 36:1309–1317. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fassbender M, Herter S, Holtappels R and
Schild H: Correlation of dendritic cell maturation and the
formation of aggregates of poly-ubiquitinated proteins in the
cytosol. Med Microbiol Immunol. 197:185–189. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zarnani AH, Moazzeni SM, Shokri F,
Salehnia M and Jeddi-Tehrani M: Kinetics of murine decidual
dendritic cells. Reproduction. 133:275–283. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sato K and Fujita S: Dendritic
cells-nature and classification. Allergol Int. 56:183–191. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Reid SD, Penna G and Adorini L: The
control of T cell responses by dendritic cell subsets. Curr Opin
Immunol. 12:114–121. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Della Porta M, Danova M, Rigolin GM,
Brugnatelli S, Rovati B, Tronconi C, Fraulini C, Russo Rossi A,
Riccardi A and Castoldi G: Dendritic cells and vascular endothelial
growth factor in colorectal cancer: Correlations with
clinicobiological findings. Oncology. 68:276–284. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Parajuli N, Müller-Holzner E, Böck G,
Werner ER, Villunger A and Doppler W: Infiltrating
CD11b+CD11c+ cells have the potential to
mediate inducible nitric oxide synthase-dependent cell death in
mammary carcinomas of HER-2/neu transgenic mice. Int J Cancer.
126:896–908. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ke Q, Wang Y and You H: Effect of mouse
liver-derived B220+/DEC205+ dendritic cells
on hepatic metastases from colonic cancer in vivo. Chin J Anatomy.
32:724–727. 2009.(In Chinese).
|
|
11
|
Min W, Cortes U, Herceg Z, Tong WM and
Wang ZQ: Deletion of the nuclear isoform of poly(ADP-ribose)
glycohydrolase (PARG) reveals its function in DNA repair, genomic
stability and tumorigenesis. Carcinogenesis. 31:2058–2065. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cuzzocrea S, Mazzon E, Genovese T,
Crisafulli C, Min WK, Di Paola R, Muià C, Li JH, Malleo G, Xu W, et
al: Role of poly(ADP-ribose) glycohydrolase in the development of
inflammatory bowel disease in mice. Free Radic Biol Med. 42:90–105.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li QZ, Wang YL and Li X: Lentivirus
PARG-shRNA transfection decreases matrix adhesion, migration
and invasion potencies of colon carcinoma lovo cells. Basic Clin
Med. 30:237–241. 2010.(In Chinese).
|
|
14
|
Fauzee NJ, Li Q, Wang YL and Pan J:
Silencing poly (ADP-Ribose) glycohydrolase (PARG) expression
inhibits growth of human colon cancer cells in vitro via
PI3K/Akt/NFκ-B pathway. Pathol Oncol Res. 18:191–199. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wu WQ, Wang YL, Pan J and Yan JX:
PARG silencing inhibits lymphangiogenesis in mouse colonal
carcinoma in vitro. Basic Clin Med. 31:625–629. 2011.(In
Chinese).
|
|
16
|
Liu HY, Huang ZL, Yang GH, Lu WQ and Yu
NR: Inhibitory effect of modified citrus pectin on liver metastases
in a mouse colon cancer model. World J Gastroenterol. 14:7386–7391.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Botta D and Jacobson MK: Identification of
a regulatory segment of poly(ADP-ribose) glycohydrolase.
Biochemistry. 49:7674–7682. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Miwa M, Tanaka M, Matsushima T and
Sugimura T: Purification and properties of glycohydrolase from calf
thymus splitting ribose-ribose linkages of poly(adenosine
diphosphate ribose). J Biol Chem. 249:3475–3482. 1974.PubMed/NCBI
|
|
19
|
Blenn C, Wyrsch P, Bader J, Bollhalder M
and Althaus FR: Poly(ADP-ribose)glycohydrolase is an upstream
regulator of Ca2+ fluxes in oxidative cell death. Cell
Mol Life Sci. 68:1455–1466. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Frizzell KM, Gamble MJ, Berrocal JG, Zhang
T, Krishnakumar R, Cen Y, Sauve AA and Kraus WL: Global analysis of
transcriptional regulation by poly(ADP-ribose) polymerase-1 and
poly(ADP-ribose) glycohydrolase in MCF-7 human breast cancer cells.
J Biol Chem. 284:33926–33938. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chandak PG, Gaikwad AB and Tikoo K:
Gallotannin ameliorates the development of streptozotocin-induced
diabetic nephropathy by preventing the activation of PARP.
Phytother Res. 23:72–77. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bannwart CF, Nakaira-Takahagi E, Golim MA,
de Medeiros LT, Romao M, Weel IC and Peracoli MT: Downregulation of
nuclear factor-kappa B (NF-kappaB) pathway by silibinin in human
monocytes challenged with Paracoccidioides brasiliensis. Life Sci.
86:880–886. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bar-Shai M, Carmeli E and Reznick AZ: The
role of NF-kappaB in protein breakdown in immobilization, aging,
and exercise: From basic processes to promotion of health. Ann NY
Acad Sci. 1057:431–447. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cai D, Frantz JD, Tawa NE Jr, Melendez PA,
Oh BC, Lidov HG, Hasselgren PO, Frontera WR, Lee J, Glass DJ, et
al: IKKbeta/NF-kappaB activation causes severe muscle wasting in
mice. Cell. 119:285–298. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hayden MS, West AP and Ghosh S: NF-kappaB
and the immune response. Oncogene. 25:6758–6780. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zerfaoui M, Errami Y, Naura AS, Suzuki Y,
Kim H, Ju J, Liu T, Hans CP, Kim JG, Abd Elmageed ZY, et al:
Poly(ADP-ribose) polymerase-1 is a determining factor in
Crm1-mediated nuclear export and retention of p65 NF-kappa B upon
TLR4 stimulation. J Immunol. 185:1894–1902. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bartha E, Solti I, Kereskai L, Lantos J,
Plozer E, Magyar K, Szabados E, Kálai T, Hideg K, Halmosi R, et al:
PARP inhibition delays transition of hypertensive cardiopathy to
heart failure in spontaneously hypertensive rats. Cardiovasc Res.
83:501–510. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Williams AC, Smartt H, HZadeh AM,
MacFarlane M, Paraskeva C and Collard TJ: Insulin-like growth
factor binding protein 3 (IGFBP-3) potentiates TRAIL-induced
apoptosis of human colorectal carcinoma cells through inhibition of
NF-kappa B. Cell Death Differ. 14:137–145. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Fang K, Chen SP, Lin CW, Cheng WC and
Huang HT: Ellipticine-induced apoptosis depends on Akt
translocation and signaling in lung epithelial cancer cells. Lung
Cancer. 63:227–234. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yadav VR, Prasad S, Gupta SC, Sung B,
Phatak SS, Zhang S and Aggarwal BB: 3-Formylchromone interacts with
cysteine residue 38 in p65 and with cysteine residue 179 in IκBα
kinase, leading to downregulation of NF-κB-regulated gene products
and sensitization of tumor cells. J Biol Chem. 2011:
|
|
31
|
Baugé C, Attia J, Leclercq S, Pujol JP,
Galéra P and Boumédiene K: Interleukin-1beta up-regulation of Smad7
via NF-kappaB activation in human chondrocytes. Arthritis Rheum.
58:221–226. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Frangogiannis NG: The immune system and
cardiac repair. Pharmacol Res. 58:88–111. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chen J and Liu XS: Development and
function of IL-10 IFN- gamma-secreting CD4+ T cells. J
Leukoc Biol. 86:1305–1310. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Schmidt-Weber CB and Blaser K: Regulation
and role of transforming growth factor-beta in immune tolerance
induction and inflammation. Curr Opin Immunol. 16:709–716. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Bellik L, Gerlini G, Parenti A, Ledda F,
Pimpinelli N, Neri B and Pantalone D: Role of conventional
treatments on circulating and monocyte-derived dendritic cells in
colorectal cancer. Clin Immunol. 121:74–80. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Schröder S, Schwarz W, Rehpenning W,
Löning T and Böcker W: Dendritic/Langerhans cells and prognosis in
patients with papillary thyroid carcinomas. Immunocytochemical
study of 106 thyroid neoplasms correlated to follow-up data. Am J
Clin Pathol. 89:295–300. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Lu L, Bonham CA, Liang X, Chen Z, Li W,
Wang L, Watkins SC, Nalesnik MA, Schlissel MS, Demestris AJ, et al:
Liver-derived DEC205+B220+CD19−
dendritic cells regulate T cell responses. J Immunol.
166:7042–7052. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wang Y, Zheng N, Lu Z, Wu W, Wang L, Nakao
A, Lotze MT, Langer CE, Fung JJ, Qian S, et al: In vivo expansion
of two distinct dendritic cells in mouse livers and its impact on
liver immune regulation. Liver Transpl. 12:1850–1861. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Rosenberg SA: Progress in human tumour
immunology. Nature. 411:380–384. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Bai DJ, Yang GL and Yuan HY: The study of
T lymphocyte and NK cell immune function in the patients with
gastrointestinal cancer. Med J Wuhan University. 22:142–144.
2001.(In Chinese).
|
|
41
|
Yang Z Y.L.J and Song XY: The clinical
study of immune function in lung cancer, liver cancer, colon
carcinoma and breast cancer patients. Sichuan Med J.
26:7542005.
|
|
42
|
Rubtsov YP and Rudensky AY: TGFbeta
signalling in control of T-cell-mediated self-reactivity. Nat Rev
Immunol. 7:443–453. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Li MO, Wan YY, Sanjabi S, Robertson AK and
Flavell RA: Transforming growth factor-β regulation of immune
responses. Annu Rev Immunol. 24:99–146. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Belladonna ML, Volpi C, Bianchi R, Vacca
C, Orabona C, Pallotta MT, Boon L, Gizzi S, Fioretti MC, Grohmann U
and Puccetti P: Cutting edge: Autocrine TGF-beta sustains default
tolerogenesis by IDO-competent dendritic cells. J Immunol.
181:5194–5198. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Corinti S, Albanesi C, la Sala A, Pastore
S and Girolomoni G: Regulatory activity of autocrine IL-10 on
dendritic cell functions. J Immunol. 166:4312–4318. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Rojas RE, Balaji KN, Subramanian A and
Boom WH: Regulation of human CD4+ αβ
T-cell-receptor-positive (TCR+) and γδ TCR+
T-cell responses to Mycobacterium tuberculosis by
interleukin-10 and transforming growth factor β. Infect Immun.
67:6461–6472. 1999.PubMed/NCBI
|
